CALGARY, Alberta, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Canacol Energy Ltd. (TSX: CNE) (OTCID: CNNEQ) (BVC: CNEC) ("Canacol” or the "Company”) announces that it has entered into an agreement with an ad hoc group of holders of the Company’s 5.75% senior unsecured notes due 2028 (the "DIP Credit Agreement”) for debtor-in-possession financing (the "DIP Financing”), comprised of a U.S.$45 million delayed-draw new-money term loan (the "Term Loan Tranche”) with capacity to obtain additional commitments to issue up to U.S.$22 million in letters of credit to renew and/or replace certain
FOSTER CITY, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns” or the "Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced the pricing of its upsized underwritten public offering of 16,250,000 shares of its common stock at a public offering price of $40.00 per share, before underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Terns, are expected to be $650 million, excluding any exercise of the underwriters’ option
WATERTOWN, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the pricing of its underwritten public offering of $602.0 million of shares of its common stock. Kymera is selling 7,000,000 shares of common stock in the offering, which are being sold at a public offering price of $86.00 per share. In addition, Kymera has granted the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of its
SAN FRANCISCO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced the pricing of its upsized underwritten public offering of 8,461,538 American depositary shares (ADSs), each representing three ordinary shares, at a price to the public of $65.00 per ADS and pre-funded warrants to purchase 1,538,462 ADSs at a price to the public of $64.9999 per pre-funded warrant. All of the securities in the offering are
SINGAPORE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- ChemOne Group ("ChemOne”) is pleased to announce the appointment of Dato’ Sri Mohamed Nazri Abdul Aziz as a Board Member of Pengerang Energy Complex Sdn Bhd ("PEC”) and Advisor to the Group, further enhancing ChemOne’s leadership capabilities and strategic direction.Dato’ Sri Nazri, a prominent Malaysian statesman, formerly served as a Minister in the Prime Minister’s Office, holding several key national portfolios, and most recently as Malaysia’s Ambassador to the United States. His extensive experience in international relations,
This production start follows the recent arrival of multiple full sets of knockdown components - nearly 3,000 parts per vehicle - required for building the first batch of complete pre-production FX Super One vehicles which, once assembled, will be used for testing, marketing and other planning activities in the U.S.This production milestone marks the second vehicle model to come out of the Hanford facility, named "FF aiFactory California," along with the Company’s FF 91 2.0 that is also assembled there. LOS ANGELES, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc.
CAMBRIDGE, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health ("Wave” or "Wave Life Sciences”), announced today the pricing of its previously announced underwritten public offering of 15,789,475 of its ordinary shares at a price to the public of $19.00 per ordinary share, and, in lieu of ordinary shares to certain investors, pre-funded warrants to purchase up to 2,631,578 ordinary shares at an offering price of $18.9999 per pre-funded
WALTHAM, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the pricing of an upsized underwritten public offering of 18,980,478 shares of its common stock at a public offering price of $18.44 per share. The gross proceeds to Dyne from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Dyne, are expected to be $350.0 million. All shares in the offering are being
SUMMIT, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Leapfrog Acquisition Corporation (the "Company") announced today the closing of its initial public offering of 14,375,000 units, which includes the exercise in full by the underwriters of their overallotment option to purchase 1,875,000 units. The offering was priced at $10.00 per unit, generating total gross proceeds of $143,750,000. The units commenced trading on December 5, 2025 on the Global Market tier of The Nasdaq Stock Market LLC under the symbol LFACU.The Company, which is led by Matthew R. Pollard, Abhay N. Pande and Kevin M. Murphy, is
CHICAGO, IL, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Meshflow Acquisition Corp. (the "Company”) today announced the pricing of its initial public offering of 30,000,000 units at a price of $10.00 per unit. The units are expected to be listed on The Nasdaq Global Market ("Nasdaq”) and begin trading on December 10, 2025, under the ticker symbol "MESHU”. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Only whole
TAICHUNG CITY, Taiwan, Dec. 09, 2025 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) ("J-Star” or the "Company”), a leading provider of innovative carbon fiber and composite solutions across a wide range of applications including personal sports equipment, healthcare products, automobile parts, resin systems, and research and development services, today announced the results of the shareholder votes from its 2025 general meeting of shareholders (the "Meeting”). The Meeting was conducted on December 9, 2025.At the Meeting, shareholders of the Company approved the proposals
BRISBANE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. ("Vera Therapeutics”), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunologic diseases, today announced the pricing of an underwritten public offering of 6,138,108 shares of its Class A common stock at a price to the public of $42.50 per share.The gross proceeds to Vera Therapeutics from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately
Shenzhen, Dec. 09, 2025 (GLOBE NEWSWIRE) -- As the holiday shopping season hits full swing, SKG, the world’s leading smart massager brand, has launched its most advanced lineup of wearable deep tissue massagers-just in time to become the most functional and thoughtful gifts of the year. Designed for people suffering from muscle tension, poor circulation, and tech-induced strain, SKG’s intelligent massagers offer powerful at-home relief for neck, shoulder, and foot pain, without the cost or hassle of spa appointments.These devices make for ideal holiday gifts across all age groups-from
BEIJING, Dec. 09, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that over 20 studies of its novel BTK inhibitor orelabrutinib were presented at the 67th Annual Meeting of the American Society of Hematology (ASH).Orelabrutinib has demonstrated remarkable efficacy and safety in multiple lymphoma studies, including marginal zone lymphoma (MZL), mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), primary central nervous
The TEAM at Fiesta Productions is Bringing Its Unique MAGIC to the 2026 Rose Parade® and Sharing a Behind the Scenes Preview of the WOW Moments it Will Be Delivering!IRWINDALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- The 137th Rose Parade® will feature some familiar "faces” and welcome a number of new ones when communities, companies and organizations once again sponsor floats to entertain and amaze the public on January 1, 2026!On December 17, 2025, Fiesta Productions in partnership with the San Francisco Travel Association, will be hosting a rare sneak peek at the incredible float
FINDLAY, OH, Dec. 09, 2025 (GLOBE NEWSWIRE) -- FINDLAY, OH - December 10, 2025 - -Dr. Andrea Adams-Miller, CEO of The RED Carpet Connection, LLC and Founder of The SubConscious Connection, LLC, master neuroscientist and executive consultant, offers expert analysis on how performers maintain emotional clarity during immersive roles. The topic has gained renewed relevance as discussion grows about the emotional demands of the two-part Wicked film series and the transformation Ariana Grande undergoes as Galinda becomes Glinda.In the films, Galinda begins as an image-driven figure shaped by social
Hong Kong, Dec. 09, 2025 (GLOBE NEWSWIRE) -- JM Group Limited (the "Company” or "JMG”), a Hong Kong-headquartered sourcing and wholesale solutions provider for a wide array of consumer products, today announced the pricing of its initial public offering (the "Offering”) of 3,750,000 ordinary shares (the "Ordinary Shares”) at a public offering price of $4 per share for total gross proceeds of $15,000,000, before deducting underwriting discounts and other offering expenses.The Ordinary Shares of the Company have been approved for listing on the NYSE American and commenced trading on
Company prioritizes its interests in other properties, including Airline and Astro ProjectsCALGARY, Alberta, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Global Uranium Corp. ("Global Uranium” or the "Company”) announces that it has terminated its option agreement (the "Option Agreement”) with Forum Energy Metals Corp. ("Forum”) relating to the Northwest Athabasca uranium project ("NWA Project”) in Saskatchewan. As a result, the Company does not hold any interest in the NWA Project. The Company’s decision follows a strategic review of the Company’s portfolio of property interests, and
LONG BEACH, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB) ("Rocket Lab” or "the Company”), a global leader in launch services and space systems, today announced it is expediting a dedicated Electron mission for the Korea Advanced Institute of Science and Technology (KAIST) and is scheduling the launch from Launch Complex 1 in less than 24 hours’ time.The mission, named ‘Bridging The Swarm’, is scheduled to launch no earlier than Thursday, December 11 UTC from Rocket Lab Launch Complex 1 in New Zealand. The mission now precedes the upcoming launch for
TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB) ("RWB” or the "Company”) announces that, further to its news release dated December 1, 2025, it has issued 375,000 common shares at a deemed price of $0.035 per share to a former consultant to settle certain outstanding obligations for past services.The securities issued pursuant to the settlement are subject to a statutory hold period of four months and one day in accordance with applicable securities laws.This news release does not constitute an offer to sell or a solicitation of an offer to buy any
